LEFEVRE PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LEFEVRE PHARMA
Largest movements
- Tangible fixed assets +€31,654
up €31,654 (+2.9%), from €1.1m to €1.1m
of which Furniture and vehicles: +€62,198
- Cash -€28,441
down €28,441 (-92.7%), from €30,688 to €2,247
mainly Investment in fixed assets (net) (-€73,921) and Trade debts (-€55,768)
- Receivables within one year -€26,546
down €26,546 (-17.9%), from €148,708 to €122,163
of which Other amounts receivable: -€42,726
- Intangible fixed assets -€17,857
down €17,857 (-16.7%), from €107,143 to €89,286
- Trade debts -€55,768
down €55,768 (-22.8%), from €244,677 to €188,908
- Debts after one year -€36,917
down €36,917 (-4.2%), from €885,602 to €848,685
- Reserves +€35,000
up €35,000 (+108.6%), from €32,242 to €67,242
- Tax, wage and social debts +€30,197
up €30,197 (+70.9%), from €42,604 to €72,801
of which Remuneration and social security: +€17,607
- Profit (loss) carried forward +€22,478
up €22,478 (+12.8%), from €176,211 to €198,689
- Gross operating margin +€106,870
up €106,870 (+46.1%), from €231,677 to €338,547
- Staff costs +€53,610
up €53,610 (+53.8%), from €99,619 to €153,229
- Depreciation +€13,930
up €13,930 (+30.2%), from €46,194 to €60,124
- Taxes +€12,382
up €12,382 (+203.8%), from €6,076 to €18,457
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,554,360 | €1,526,981 | -€27,379 | -1.8% |
| Fixed assets | 21/28 | €1,197,407 | €1,211,204 | +€13,797 | +1.2% |
| Intangible fixed assets | 21 | €107,143 | €89,286 | -€17,857 | -16.7% |
| Tangible fixed assets | 22/27 | €1,090,265 | €1,121,918 | +€31,654 | +2.9% |
| Land and buildings | 22 | €325,345 | €309,539 | -€15,806 | -4.9% |
| Plant, machinery and equipment | 23 | €340,997 | €326,259 | -€14,738 | -4.3% |
| Furniture and vehicles | 24 | €5,135 | €67,333 | +€62,198 | +1211.2% |
| Assets under construction and advance payments | 27 | €418,787 | €418,787 | = | 0.0% |
| Current assets | 29/58 | €356,953 | €315,777 | -€41,176 | -11.5% |
| Stocks and contracts in progress | 3 | €173,009 | €180,245 | +€7,236 | +4.2% |
| Stocks | 30/36 | €173,009 | €180,245 | +€7,236 | +4.2% |
| Amounts receivable within one year | 40/41 | €148,708 | €122,163 | -€26,546 | -17.9% |
| Trade receivables | 40 | €95,054 | €111,234 | +€16,180 | +17.0% |
| Other amounts receivable | 41 | €53,654 | €10,928 | -€42,726 | -79.6% |
| Cash at bank and in hand | 54/58 | €30,688 | €2,247 | -€28,441 | -92.7% |
| Deferred charges and accrued income | 490/1 | €4,548 | €11,122 | +€6,574 | +144.6% |
| Total equity and liabilities | 10/49 | €1,554,360 | €1,526,981 | -€27,379 | -1.8% |
| Equity | 10/15 | €228,913 | €286,391 | +€57,478 | +25.1% |
| Contributions | 10/11 | €20,460 | €20,460 | = | 0.0% |
| Reserves | 13 | €32,242 | €67,242 | +€35,000 | +108.6% |
| Distributable reserves | 133 | €32,242 | €67,242 | +€35,000 | +108.6% |
| Profit (loss) carried forward | 14 | €176,211 | €198,689 | +€22,478 | +12.8% |
| Amounts payable | 17/49 | €1,325,447 | €1,240,589 | -€84,857 | -6.4% |
| Amounts payable after more than one year | 17 | €885,602 | €848,685 | -€36,917 | -4.2% |
| Financial debts | 170/4 | €885,602 | €848,685 | -€36,917 | -4.2% |
| Amounts payable within one year | 42/48 | €439,605 | €391,183 | -€48,422 | -11.0% |
| Current portion of amounts payable after more than one year | 42 | €112,624 | €107,213 | -€5,411 | -4.8% |
| Financial debts | 43 | €32,000 | €22,061 | -€9,939 | -31.1% |
| Credit institutions | 430/8 | €32,000 | €22,061 | -€9,939 | -31.1% |
| Trade debts | 44 | €244,677 | €188,908 | -€55,768 | -22.8% |
| Suppliers | 440/4 | €244,677 | €188,908 | -€55,768 | -22.8% |
| Taxes, remuneration and social security | 45 | €42,604 | €72,801 | +€30,197 | +70.9% |
| Taxes | 450/3 | €20,989 | €33,579 | +€12,590 | +60.0% |
| Remuneration and social security | 454/9 | €21,615 | €39,222 | +€17,607 | +81.5% |
| Other amounts payable | 47/48 | €7,700 | €200 | -€7,500 | -97.4% |
| Accrued charges and deferred income | 492/3 | €240 | €722 | +€481 | +200.4% |
| Remuneration, social security and pensions | 62 | €99,619 | €153,229 | +€53,610 | +53.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €46,194 | €60,124 | +€13,930 | +30.2% |
| Other operating charges | 640/8 | €2,783 | €3,934 | +€1,151 | +41.4% |
| Non-recurring operating charges | 66A | €16,672 | €487 | -€16,185 | -97.1% |
| Gross operating margin | 9900 | €231,677 | €338,547 | +€106,870 | +46.1% |
| Operating profit (loss) | 9901 | €66,409 | €120,774 | +€54,364 | +81.9% |
| Financial income | 75/76B | €1,169 | €0 | -€1,168 | -100.0% |
| Recurring financial income | 75 | €121 | €0 | -€121 | -99.6% |
| Non-recurring financial income | 76B | €1,047 | - | -€1,047 | |
| Financial charges | 65/66B | €42,580 | €44,839 | +€2,259 | +5.3% |
| Recurring financial charges | 65 | €42,580 | €44,839 | +€2,259 | +5.3% |
| Profit (loss) for the period before taxes | 9903 | €24,998 | €75,935 | +€50,937 | +203.8% |
| Income taxes | 67/77 | €6,076 | €18,457 | +€12,382 | +203.8% |
| Profit (loss) for the period | 9904 | €18,922 | €57,478 | +€38,556 | +203.8% |
| Profit (loss) for the period to be appropriated | 9905 | €18,922 | €57,478 | +€38,556 | +203.8% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.